Staar Surgical (STAA) EPS (Weighted Average and Diluted) (2010 - 2026)

Staar Surgical has reported EPS (Weighted Average and Diluted) for 17 years, with the latest figure at $0.1 in Q2 2026.

• For the quarter ending Q2 2026, EPS (Weighted Average and Diluted) rose 109.09% year-over-year to $0.1; the trailing twelve-month figure through Apr 2026 stood at -$0.42 (up 70.83% YoY), and the FY2026 full-year result was -$1.62, down 295.12% from the prior year.
• EPS (Weighted Average and Diluted) for Q2 2026 stood at $0.1, up from -$0.36 in the prior quarter.
• The five-year high for EPS (Weighted Average and Diluted) was $0.26 in Q3 2022, with the low at -$1.1 in Q1 2025.
• Historically, EPS (Weighted Average and Diluted) has averaged -$0.04 across 5 years, with a median of $0.12 in 2023.
• Annual changes were most pronounced in 2025 — EPS (Weighted Average and Diluted) sank 1471.43% — and 2026, when it jumped 109.09%.
• Staar Surgical's EPS (Weighted Average and Diluted) stood at $0.13 in 2022, then grew by 23.08% to $0.16 in 2023, then slumped by 531.25% to -$0.69 in 2024, then surged by 126.09% to $0.18 in 2025, then sank by 44.44% to $0.1 in 2026.
• The last three EPS (Weighted Average and Diluted) figures came in at $0.1 (Q2 2026), -$0.36 (Q1 2026), and $0.18 (Q3 2025), per Business Quant data.